GlycoMimetics Ownership | Who Owns GlycoMimetics?

GlycoMimetics Ownership Summary

GlycoMimetics is owned by 19.48% institutional investors, 2.66% insiders, and 77.86% retail investors. Artal group is the largest institutional shareholder, holding 13.33% of GLYC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.98% of its assets in GlycoMimetics shares.

GLYC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	GlycoMimetics	19.48%	2.66%	77.86%
Sector	Healthcare Stocks	279.42%	10.64%	-190.05%
Industry	Biotech Stocks	64.05%	10.69%	25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Artal group	8.59M	13.33%	$2.42M
Goldman sachs group	804.34K	1.25%	$226.50K
Blackrock	723.18K	1.12%	$203.65K
Bridgeway capital management	81.80K	0.13%	$23.04K
Torno capital	74.70K	0.12%	$21.04K
Renaissance	41.15K	0.06%	$10.25K
Susquehanna group, llp	40.77K	0.06%	$10.15K
Tower research capital llc (trc)	19.56K	0.03%	$4.87K
Millennium management	13.85K	0.02%	$2.91K
Pine valley investments ltd liability	12.52K	0.02%	$3.12K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Artal group	8.59M	0.06%	$2.42M
Torno capital	74.70K	0.00%	$21.04K
Bridgeway capital management	81.80K	0.00%	$23.04K
Pine valley investments ltd liability	12.52K	0.00%	$3.12K
Tower research capital llc (trc)	19.56K	0.00%	$4.87K
Blackrock	723.18K	-	$203.65K
Gsa capital partners llp	-	-	-
National bank of canada /fi/	-	-	-
Vanguard personalized indexing management	-	-	-
Marshall wace, llp	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Torno capital	74.70K	0.00%	74.70K
Susquehanna group, llp	40.77K	-	40.77K
Tower research capital llc (trc)	19.56K	0.00%	19.56K
Royal bank of canada	2.32K	-	319.00
Artal group	8.59M	0.06%	-

Top Sellers

Holder	Shares	% Assets	Change
Bvf inc/il	-	-	-9.54M
Logos global management lp	-	-	-5.40M
Adage capital partners gp	-	-	-5.09M
Nea management company	-	-	-3.84M
Vr adviser	-	-	-3.00M

New Positions

Holder	Shares	% Assets	Change	Value
Torno capital	74.70K	0.00%	74.70K	$21.04K
Susquehanna group, llp	40.77K	-	40.77K	$10.15K
Tower research capital llc (trc)	19.56K	0.00%	19.56K	$4.87K

Sold Out

Holder	Change
Fmr	-67.00
Jpmorgan chase	-126.00
Wells fargo & company/mn	-383.00
Old point trust & financial services n a	-500.00
National bank of canada /fi/	-600.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	3	-92.50%	12,558,116	-58.62%	19	0.88%	-	-100.00%	1	-75.00%
Dec 31, 2024	15	-55.88%	5,507,448	-69.04%	8	1.12%	7	-53.33%	1	-90.91%
Sep 30, 2024	33	-19.51%	17,775,290	-30.46%	27	1.75%	14	16.67%	11	-38.89%
Jun 30, 2024	41	-49.38%	25,560,030	-30.64%	39	1.21%	12	-75.51%	18	100.00%
Mar 31, 2024	81	32.79%	36,848,906	4.98%	57	1.92%	49	81.48%	9	-35.71%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.93M	2.98%	-1.00
Vanguard Total Stock Mkt Idx Inv	1.93M	2.98%	-
Wellington CIF Biotechnology	1.17M	1.82%	-43.10K
Vanguard Institutional Extnd Mkt Idx Tr	730.60K	1.13%	-
MEDICAL BioHealth EUR Acc	609.48K	0.95%	-
Fidelity Extended Market Index	318.11K	0.49%	-1.42K
BlackRock Extended Equity Market K	107.17K	0.17%	-46.00
Extended Equity Market Fund K	106.04K	0.16%	325.00
iShares Micro-Cap ETF	101.27K	0.16%	-
Fidelity Total Market Index	80.84K	0.13%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 08, 2024	Invus Public Equities, L.P.	-	Sell	$50.01K
Aug 07, 2024	Invus Public Equities, L.P.	-	Sell	$11.20K
Aug 05, 2024	Invus Public Equities, L.P.	-	Sell	$31.00K
Aug 06, 2024	Invus Public Equities, L.P.	-	Sell	$10.19K
Aug 01, 2024	Invus Public Equities, L.P.	-	Sell	$13.74K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	9
2024 Q2	3	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	2	-

GLYC Ownership FAQ

Who Owns GlycoMimetics?

GlycoMimetics shareholders are primarily institutional investors at 19.48%, followed by 2.66% insiders and 77.86% retail investors. The average institutional ownership in GlycoMimetics's industry, Biotech Stocks , is 64.05%, which GlycoMimetics falls below.

Who owns the most shares of GlycoMimetics?

GlycoMimetics’s largest shareholders are Artal group (8.59M shares, 13.33%), Goldman sachs group (804.34K shares, 1.25%), and Blackrock (723.18K shares, 1.12%). Together, they hold 15.70% of GlycoMimetics’s total shares outstanding.

Does Blackrock own GlycoMimetics?

Yes, BlackRock owns 1.12% of GlycoMimetics, totaling 723.18K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 203.65K$. In the last quarter, BlackRock decreased its holdings by -9.383K shares, a -1.28% change.

Who is GlycoMimetics’s biggest shareholder by percentage of total assets invested?

Artal group is GlycoMimetics’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 8.59M GlycoMimetics shares, valued at 2.42M$.

Who is the top mutual fund holder of GlycoMimetics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of GlycoMimetics shares, with 2.98% of its total shares outstanding invested in 1.93M GlycoMimetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools